Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Abacavir versus other nucleoside reverse transcriptase inhibitor (NRTI) backbone therapies for treatment of HIV infection

Este protocolo ha sido retirado

Información

DOI:
https://doi.org/10.1002/14651858.CD009390.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 02 febrero 2018see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:
  1. Grupo Cochrane de VIH/SIDA

Copyright:
  1. Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Mario Cruciani

    Correspondencia a: Antibiotic Stewardship Programme, Azienda ULSS9 Scaligera, Verona, Italy

    [email protected]

  • Arturo J Martí‐Carvajal

    Iberoamerican Cochrane Network, Valencia, Venezuela

  • Carlo Mengoli

    Department of Histology, Microbiology and Medical Biotechnology, Università di Padova, Padova, Italy

  • Giovanni Serpelloni

    Dipartimento delle Dipendenze, ULSS 20 Verona, 37135 Verona, Italy

  • Chiara Bovo

    Direzione Sanitaria, Azienda ULSS 20, Verona, Italy

  • Graeme Moyle

    Department of HIV and Genitourinary Medicine, Chelsea and Westminster Hospital, London, UK

Version history

Published

Title

Stage

Authors

Version

2018 Feb 02

Abacavir versus other nucleoside reverse transcriptase inhibitor (NRTI) backbone therapies for treatment of HIV infection

Protocol

Mario Cruciani, Arturo J Martí‐Carvajal, Carlo Mengoli, Giovanni Serpelloni, Chiara Bovo, Graeme Moyle

https://doi.org/10.1002/14651858.CD009390.pub2

2011 Nov 09

Abacavir versus other nucleoside reverse transcriptase inhibitor (NRTI) backbone therapies for treatment of HIV infection

Protocol

Mario Cruciani, Arturo J Martí‐Carvajal, Carlo Mengoli, Giovanni Serpelloni, Chiara Bovo, Graeme Moyle

https://doi.org/10.1002/14651858.CD009390